文献速递心血管MR

血管扩张剂负荷灌注心血管磁共振对既往心肌梗死患者的预后价值

Prognostic Value of Vasodilator Stress Perfusion Cardiovascular Magnetic Resonance in Patients With Prior Myocardial Infarction.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-06-16

本研究连续纳入2008至2019年因既往心肌梗死转诊行血管扩张剂负荷心血管磁共振(CMR)的患者,随访主要不良心血管事件(心血管死亡或再发非致死性心肌梗死)。在1594例有心肌瘢痕的患者中,1401例完成随访(中位6.2年),205例发生MACE(14.6%);诱发性缺血和瘢痕范围均为MACE的独立预测因子,将CMR参数加入传统危险因素模型后判别能力提高(C统计量0.76 vs 0.62)。

要点

  • 既往心肌梗死患者中,无诱发性缺血者年MACE率3.1%,低于1-2段缺血的4.9%、3-5段的21.5%和≥6段的45.7%(均p<0.01)。
  • 诱发性缺血与瘢痕范围均为MACE的独立预测因子(多变量HR分别为2.84和1.57,均p<0.001)。
  • 将CMR参数加入传统危险因素模型后,MACE判别能力提高(C统计量0.76 vs 0.62)。

核心结论

  • 在既往心肌梗死患者中,血管扩张剂负荷CMR较传统危险因素具有独立且增量的预后价值。

研究设计与样本

  • 研究为连续纳入2008至2019年因既往心肌梗死转诊行血管扩张剂负荷CMR的患者,共1594例有心肌瘢痕,其中1401例(92%)完成随访(中位6.2年)。

关键影像表现/征象

  • CMR显示心肌瘢痕,用于评估瘢痕范围和诱发性缺血。
  • 诱发性缺血按受累节段数分为无、1-2段、3-5段和≥6段。

诊断标准与关键数值

  • 无诱发性缺血者年MACE率3.1%,1-2段缺血者4.9%,3-5段缺血者21.5%,≥6段缺血者45.7%(均p<0.01)。
  • Kaplan-Meier分析中,诱发性缺血与MACE的HR为3.52(95%CI 2.67-4.65),瘢痕范围与MACE的HR为1.66(95%CI 1.53-2.18),均p<0.001。
  • 多变量逐步Cox回归中,诱发性缺血(HR 2.84,95%CI 2.14-3.78)和瘢痕范围(HR 1.57,95%CI 1.44-1.72)均为MACE的独立预测因子,均p<0.001。
  • 将CMR参数加入含传统危险因素的模型后,MACE判别能力提高(C统计量0.76 vs 0.62)。

临床应用与阅片要点

  • 在既往心肌梗死患者中,血管扩张剂负荷CMR显示的诱发性缺血和瘢痕范围可用于MACE风险分层。
  • 上述预后关联在有症状和无症状患者中均显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to assess the incremental prognostic value of vasodilator stress cardiovascular magnetic resonance (CMR) in patients with prior myocardial infarction (MI).

BACKGROUND: Recurrent MI is a major cause of mortality and morbidity among MI survivors.

METHODS: Between 2008 and 2019, consecutive patients with prior MI referred for stress CMR were followed up for the occurrence of major adverse cardiovascular events (MACE), defined by cardiovascular mortality or recurrent nonfatal MI. Uni- and multivariable Cox regressions were performed to determine the prognostic value of inducible ischemia and the extent of myocardial scar.

RESULTS: Among 1,594 patients with prior MI and myocardial scar on CMR, 1,401 (92%) (68.2 ± 11.0 years; 61.4% men) completed the follow-up (median: 6.2 years), and 205 had MACE (14.6%). Patients without inducible ischemia experienced a lower annual rate of MACE (3.1%) than those with 1-2 (4.9%), 3-5 (21.5%), or ≥6 segments of ischemia (45.7%) (all p < 0.01). Using Kaplan-Meier analysis, the presence of inducible ischemia and the extent of scar were associated with MACE (hazard ratio [HR]:3.52; 95% confidence interval [CI]: 2.67 to 4.65 and HR: 1.66; 95% CI: 1.53 to 2.18, respectively; both p < 0.001). In multivariable stepwise Cox regression, the presence of ischemia and the extent of scar were independent predictors of MACE (HR: 2.84; 95% CI: 2.14 to 3.78 and HR: 1.57; 95% CI: 1.44 to 1.72, respectively; both p < 0.001). These findings were significant in both symptomatic and asymptomatic patients. The addition of CMR parameters to the model including traditional risk factors resulted in a better discrimination for MACE (C-statistic: 0.76 vs. 0.62).

CONCLUSIONS: In patients with prior MI, vasodilator stress CMR has independent and incremental prognostic value over traditional risk factors.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Pezel T, Garot P, Kinnel M, et al. Prognostic Value of Vasodilator Stress Perfusion Cardiovascular Magnetic Resonance in Patients With Prior Myocardial Infarction. JACC Cardiovasc Imaging. 2021. PMID: 34147458. doi:10.1016/j.jcmg.2021.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。